首页 > 市场调查报告书 > 医疗设备

放射肿瘤市场规模、份额和成长分析（按类型、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898365

放射肿瘤市场规模、份额和成长分析（按类型、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Radiation Oncology Market Size, Share, and Growth Analysis, By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Application (Prostate Cancer, Breast Cancer), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 172 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球放射肿瘤学市场规模将达到 118.1 亿美元，到 2025 年将成长至 132.7 亿美元，到 2033 年将成长至 335.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 12.3%。

全球放射肿瘤市场正经历显着成长，主要驱动因素是人口老化、生活方式改变和环境因素导致全球癌症发生率上升。强度调控放射治疗放射线手术(SRS) 等放射治疗技术的创新显着提高了治疗精确度和病患疗效。世界卫生组织 (WHO) 报告称，每年有数百万例癌症病例和死亡病例，凸显了有效治疗方案的紧迫性。为此，主要产业参与者正采取策略性措施来巩固其市场地位，例如近期获得监管部门核准以及建立旨在推进创新治疗方法的合作关係。这种不断变化的市场格局凸显了对先进癌症治疗方案的明确需求，从而刺激了对各种治疗方法的投资和研发。

全球放射肿瘤市场按类型、应用、最终用户和地区进行细分。依类型划分，可分为体外放射治疗和体内放射治疗。依应用划分，可分为摄护腺癌、乳癌、肺癌、大肠癌、妇科癌症、子宫颈癌、阴茎癌等癌症。依最终用户划分，可分为医院、专科诊所及其他机构。按地区划分，可分为北美、欧洲、亚太、中东和非洲以及拉丁美洲。

全球放射肿瘤市场驱动因素

全球放射肿瘤市场正经历显着成长，这主要得益于全球癌症发生率的不断攀升。癌症仍然是主要的死亡原因之一，推动了对先进疗法（尤其是放射疗法）的需求。这种需求的成长促使人们对放射和肿瘤技术进行了大量投资，进一步促进了市场扩张。随着医疗系统努力拓展治疗选择并改善患者预后，创新放射肿瘤解决方案的持续开发和应用在应对全球癌症发病率不断上升带来的挑战方面发挥关键作用。

限制全球放射肿瘤市场发展的因素

全球放射肿瘤市场面临严峻挑战，主要原因是放射治疗及相关设备高成本。放射治疗中使用的先进技术价格往往高得令人望而却步，许多医疗机构，尤其是中低收入地区的医疗机构，难以负担。这种经济障碍限制了放射治疗在癌症治疗中的广泛应用，最终阻碍了市场的成长和发展。因此，这些医疗资源匮乏地区病患获得基本放射肿瘤服务的机会有限，进而影响了病患预后的改善。

全球放射肿瘤市场趋势

全球放射肿瘤学市场的一个显着趋势是质子疗法的日益普及，这得益于其能够更精准地靶向癌细胞，并将邻近健康组织的损伤降至最低。这种创新治疗方法不仅改善了某些癌症的治疗效果，也满足了患者对微创治疗方法和更少潜在副作用的需求。随着医疗机构逐渐认识到质子疗法的优势，预计需求将激增，从而推动放射肿瘤技术的持续进步和投资。这一转变反映了全球肿瘤学领域向个人化医疗和改善患者照护方向发展的更广泛努力。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Varian Medical Systems, Inc.（Siemens Healthineers AG）（US）
Elekta AB（Sweden）
Accuray Incorporated（US）
IBA Radiopharma Solutions（Belgium）
BD（Becton, Dickinson and Company）（US）
Isoray Inc.（US）
Mevion Medical Systems（US）
Nordion, Inc.（Sotera Health）（Canada）
NTP Radioisotopes SOC Ltd.（South Africa）
Curium（France）
ViewRay Technologies, Inc.（US）
IBA Worldwide（Belgium）
Provision Healthcare（US）
Canon Inc.（Japan）
Hitachi Ltd.（Japan）
Icad Inc.（US）
Ion Beam Applications（Belgium）
Panacea Medical Technologies Pvt. Ltd.（India）
P-Cure Ltd.（Israel）

结论与建议

简介目录

Product Code: SQMIG35A2944

Global Radiation Oncology Market size was valued at USD 11.81 Billion in 2024 and is poised to grow from USD 13.27 Billion in 2025 to USD 33.56 Billion by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).

The global radiation oncology market is witnessing substantial growth, primarily fueled by the rising incidence of cancer globally due to an aging population, lifestyle changes, and environmental factors. Breakthroughs in radiation therapy technologies, such as intensity-modulated radiation therapy and stereotactic radiosurgery, have significantly improved treatment precision and patient outcomes. The World Health Organization reports millions of cancer cases and deaths annually, indicating an urgent need for effective treatment solutions. In response, key industry players are implementing strategic initiatives to strengthen their market positions, exemplified by recent regulatory approvals and collaborations aimed at advancing innovative therapies. This evolving landscape highlights a clear demand for enhanced oncology solutions, driving investment and development in diverse therapeutic approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiation Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiation Oncology Market Segments Analysis

Global Radiation Oncology Market is segmented on the type, application, end user, and region. By type, market is segmented into External Beam Radiation Therapy, and Internal Beam Radiation Therapy. By application, market is segmented into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Gynecological Cancer, Cervical Cancer, Penile Cancer, and Others. By end user, market is segmented into Hospitals, Specialty Clinics, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Radiation Oncology Market

The global radiation oncology market is experiencing significant growth, primarily fueled by the rising prevalence of cancer across the world. As cancer remains a leading cause of mortality, there is an escalating demand for advanced treatments, particularly radiation therapy. This growing need has prompted substantial investments in radiation and oncology technologies, further contributing to the market's expansion. As healthcare systems strive to enhance treatment options and improve patient outcomes, the continuous development and adoption of innovative radiation oncology solutions play a crucial role in addressing the challenges posed by increasing cancer rates globally.

Restraints in the Global Radiation Oncology Market

The global radiation oncology market faces significant challenges due to the high costs associated with radiation therapy and its related equipment. The advanced technologies utilized in radiation therapy often come with substantial price tags, rendering them unaffordable for numerous healthcare providers, particularly in low- and middle-income regions. This financial barrier restricts the broader implementation of radiation treatment for cancer, ultimately impeding the growth and development of the market. As a result, the limited accessibility to essential radiation oncology services hinders the potential for improving patient outcomes in these underserved areas.

Market Trends of the Global Radiation Oncology Market

A significant trend in the Global Radiation Oncology market is the rising adoption of proton therapy, driven by its enhanced precision in targeting malignant cells while minimizing harm to adjacent healthy tissues. This innovative approach not only improves treatment outcomes for specific cancers but also appeals to patients seeking less invasive options with potentially fewer side effects. As healthcare providers increasingly recognize the benefits of proton therapy, demand is expected to surge, catalyzing ongoing advancements and investments in radiation oncology technologies. This shift reflects a broader commitment to personalized medicine and improved patient care in oncology practices worldwide.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Radiation Oncology Market Size by Type & CAGR (2026-2033)

Market Overview
External Beam Radiation Therapy
Internal Beam Radiation Therapy

Global Radiation Oncology Market Size by Application & CAGR (2026-2033)

Market Overview
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Gynecological Cancer
Cervical Cancer
Penile Cancer
Others

Global Radiation Oncology Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Radiation Oncology Market Size & CAGR (2026-2033)

North America (Type, Application, End User)
- US
- Canada
Europe (Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Varian Medical Systems, Inc. (Siemens Healthineers AG) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accuray Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Radiopharma Solutions (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isoray Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mevion Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion, Inc. (Sotera Health) (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NTP Radioisotopes SOC Ltd. (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViewRay Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Worldwide (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Provision Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Icad Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ion Beam Applications (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Medical Technologies Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
P-Cure Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments